Cellectis filed reports with the SEC and its stock was listed on Nasdaq on September 15, 2026.

The entities involved

• Cellectis →

  biopharmaceutical company

  • An investigation involving Cellectis was reported from New York City.Fri 18:53
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• Harmony Biosciences filed with the SEC and was listed on the Nasdaq stock exchange on September 9, 2026.Sep 10
• Texas Instruments filed with the SEC and its stock was listed on Nasdaq on August 18, 2026.Aug 18
• CARIS filed a transaction with the SEC and its stock is listed on Nasdaq.Fri 10:15
• CSX Corporation filed required reports with the SEC and its stock trades on the Nasdaq exchange.Aug 30
• Innospec filed required reports with the Securities and Exchange Commission and listed its stock on the Nasdaq exchange.Sep 4